- Home
- JEM vs SAVA Comparison
JEM vs SAVA Comparison
Compare JEM & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEM
- SAVA
- Stock Information
- Founded
- JEM 2021
- SAVA 1998
- Country
- JEM Hong Kong
- SAVA United States
- Employees
- JEM N/A
- SAVA N/A
- Industry
- JEM
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- JEM
- SAVA Health Care
- Exchange
- JEM NYSE
- SAVA Nasdaq
- Market Cap
- JEM 81.7M
- SAVA 70.5M
- IPO Year
- JEM 2025
- SAVA N/A
- Fundamental
- Price
- JEM $3.72
- SAVA $2.21
- Analyst Decision
- JEM
- SAVA Buy
- Analyst Count
- JEM 0
- SAVA 2
- Target Price
- JEM N/A
- SAVA $54.50
- AVG Volume (30 Days)
- JEM 137.1K
- SAVA 842.3K
- Earning Date
- JEM 01-01-0001
- SAVA 08-07-2025
- Dividend Yield
- JEM N/A
- SAVA N/A
- EPS Growth
- JEM 13.72
- SAVA N/A
- EPS
- JEM 0.05
- SAVA N/A
- Revenue
- JEM $11,285,111.00
- SAVA N/A
- Revenue This Year
- JEM N/A
- SAVA N/A
- Revenue Next Year
- JEM N/A
- SAVA N/A
- P/E Ratio
- JEM $88.34
- SAVA N/A
- Revenue Growth
- JEM 4.38
- SAVA N/A
- 52 Week Low
- JEM $3.05
- SAVA $1.15
- 52 Week High
- JEM $7.90
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- JEM N/A
- SAVA 50.07
- Support Level
- JEM N/A
- SAVA $2.15
- Resistance Level
- JEM N/A
- SAVA $2.72
- Average True Range (ATR)
- JEM 0.00
- SAVA 0.16
- MACD
- JEM 0.00
- SAVA -0.02
- Stochastic Oscillator
- JEM 0.00
- SAVA 22.79
About JEM 707 CAYMAN HOLDINGS LIMITED
707 Cayman Holdings Ltd is a Hong Kong-based group that sells quality apparel products and provides supply chain management total solutions to its customers spanning from Western Europe, North America to the Middle East. Its comprehensive range of supply chain management total solutions includes market trend analysis, design and product development, sourcing, production management, quality control and logistics services, and its solutions encompass the total supply chain from conceptualizing the product, the selection of materials until the final delivery of finished apparel products to its customers at their nominated destinations, whether it be a designated port for shipment, its customer's warehouse or the end consumers.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.